Upsher-Smith Announces Development Agreement With Lundbeck

          Upsher-Smith Announces Development Agreement With Lundbeck

PR Newswire

MAPLE GROVE, Minn., Sept. 30, 2013

MAPLE GROVE, Minn., Sept.30, 2013 /PRNewswire/ --Upsher-Smith Laboratories,
Inc. (Upsher-Smith), a fully integrated pharmaceutical company committed to
the development of new treatments for diseases of the central nervous system,
today announced that its UK subsidiary, Proximagen Limited, has entered into a
preclinical development agreement with Denmark-based H. Lundbeck A/S
(Lundbeck) to further its research program related to protein kinase
inhibitors. This transaction is part of Upsher-Smith's long-term strategy to
advance its current product portfolio of branded drugs. Specific terms related
to the deal have not been disclosed.

(Logo: )

"Upsher-Smith is pleased to announce today's development agreement with
Lundbeck. We are very impressed with the world-class research conducted by
Lundbeck and excited about the opportunity to bring a new therapy forward that
may benefit patients," said Mark Evenstad, President and Chief Executive
Officer of Upsher-Smith.

"Forming successful alliances is a key strategic objective for Lundbeck. We
share Upsher-Smith's commitment to develop therapies that may have the
potential to improve the lives of people living with challenging medical
conditions," said Ulf Wiinberg, Chief Executive Officer of Lundbeck.

About Upsher-Smith
Upsher-Smith, founded in 1919, is an independent and privately-owned specialty
pharmaceutical company headquartered in Maple Grove, Minnesota that focuses on
product growth and innovation for branded and generic pharmaceuticals.
Upsher-Smith has a particular focus on developing therapies to assist people
suffering from central nervous system diseases, and also markets products
relating to cardiology, dermatology, and women's health. For more
information, visit

SOURCE Upsher-Smith Laboratories, Inc.

Contact: Elizabeth Likly, Kovak-Likly Communications, 203-762-8833,
Press spacebar to pause and continue. Press esc to stop.